Avat Xavier Insider Profile

Avat Xavier, CBO at Capricor Therapeutics, holds 3.00K shares in Capricor Therapeutics (Ticker: CAPR). Most recently, Avat Xavier Bought $2,500 shares of Capricor Therapeutics on Jul 07, 2022 for an estimated value of 9.32K.
Avat Xavier

Avat Xavier
Capricor Therapeutics (CAPR)

Not Ranked
Avat Xavier has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of Avat Xavier's holdings

Insider Roles

Capricor Therapeutics
Roles that Avat Xavier holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Avat Xavier

Avat Xavier's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Capricor Therapeutics
Jul 07, 2022
Informative Buy
No. of Shares
Price per Share
Link to Report
Jul 07, 2022
Informative Buy
List of latest transactions for each holding click on a transaction to see Avat Xavier's performance on stock

Avat Xavier insider profile FAQ

What is the percentage of profitable transactions made by Avat Xavier?
The percentage of profitable transactions made by Avat Xavier is ―.
    What is the average return per transaction made by Avat Xavier?
    The average return per transaction made by Avat Xavier is ―.
      What stocks does Avat Xavier hold?
      Avat Xavier holds: CAPR stocks.
        What was Avat Xavier’s latest transaction?
        Avat Xavier latest transaction was an Informative Buy of $9.32K.
          What was Avat Xavier's most profitable transaction?
          Avat Xavier’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Avat Xavier's role in Capricor Therapeutics?
            Avat Xavier's role in Capricor Therapeutics is CBO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.